Skip to main content
. 2021 Jun 8;9(6):655. doi: 10.3390/biomedicines9060655
AMI acute myocardial infarction
apoA1 apolipoprotein A1
apoB apolipoprotein B-100
apoM apolipoprotein M
apo(a) apolipoprotein small a
CVD cardiovascular diseases
ELISA enzyme-linked immunosorbent assay
FH familial hypercholesterolemia
HDL high-density lipoprotein
LCAT lecithin-cholesterol acyltransferase
LC-MS/MS liquid chromatography-tandem mass spectrometry
LDL low-density lipoprotein
LDL(−) electronegative low-density lipoprotein
LOX-1 lectin-like oxidized low-density lipoprotein receptor-1
Lp(a) lipoprotein small a
Lp-PLA2 lipoprotein associated phospholipase A2
mAb monoclonal antibody
MCP-1 monocyte chemoattractant protein-1
MM-LDL minimally modified low-density lipoprotein
MPO myeloperoxidase
NETs neutrophils extracellular traps
NF-kB nuclear factor-kappa binding protein
oxHDL oxidized high-density lipoprotein
oxLDL oxidized low-density lipoprotein
oxPC oxidized phosphatidylcholine
PC phosphatidylcholine
PON1 paraoxonase-1
PTCA percutaneous transluminal coronary angioplasty
PUFA polyunsaturated fatty acid
sdLDL small dense low-density lipoprotein
SR-A scavenger receptor type A
STEMI ST-elevation myocardial infarction
TBARS thiobarbituric acid reactive substances
TG triacylglycerol
WHHL Watanabe heritable hyperlipidemic